Search research articles
Contact Us
Filters
Showing results (191-200 of 480) with videos related to
Page
of 48
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 22, 2010
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
Tomasz Zaremba, Huw Thomas, Michael Cole, et al.
Journal of Abnormal Psychology
|
September 11, 2013
Alcohol stress response dampening during imminent versus distal, uncertain threat
Kathryn R Hefner, Christine A Moberg, Laura Y Hachiya, et al.
Frontiers in Oncology
|
April 21, 2020
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
Harriet E D Southgate, Lindi Chen, Nicola J Curtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer
M Markman, T Hakes, R Barakat, et al.
Cancers
|
July 26, 2020
Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting
Alice Bradbury, Rachel O'Donnell, Yvette Drew, et al.
Plos One
|
May 1, 2012
DRB2 is required for microRNA biogenesis in Arabidopsis thaliana
Andrew L Eamens, Ki Wook Kim, Shaun J Curtin, et al.
Journal of Bacteriology
|
April 20, 2006
Effect of chromate stress on Escherichia coli K-12
D F Ackerley, Y Barak, S V Lynch, et al.
Journal of Visualized Experiments : Jove
|
October 7, 2014
Using the threat probability task to assess anxiety and fear during uncertain and certain threat
Daniel E Bradford, Katherine P Magruder, Rachel A Korhumel, et al.
International Journal of Oral and Maxillofacial Surgery
|
June 22, 2021
Characterization and clinicopathological significance of circulating tumour cells in patients with oral squamous cell carcinoma
J Curtin, S-W Choi, P J Thomson, et al.
Cancers
|
November 26, 2022
Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling
Hannah L Smith, Elaine Willmore, Asima Mukhopadhyay, et al.
Page
of 48
Search research articles
Search
Showing results (191-200 of 480) with videos related to
Sort By:
Page
of 48
Cancer Chemotherapy and Pharmacology
|
May 22, 2010
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
Tomasz Zaremba, Huw Thomas, Michael Cole, et al.
Journal of Abnormal Psychology
|
September 11, 2013
Alcohol stress response dampening during imminent versus distal, uncertain threat
Kathryn R Hefner, Christine A Moberg, Laura Y Hachiya, et al.
Frontiers in Oncology
|
April 21, 2020
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
Harriet E D Southgate, Lindi Chen, Nicola J Curtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer
M Markman, T Hakes, R Barakat, et al.
Cancers
|
July 26, 2020
Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting
Alice Bradbury, Rachel O'Donnell, Yvette Drew, et al.
Plos One
|
May 1, 2012
DRB2 is required for microRNA biogenesis in Arabidopsis thaliana
Andrew L Eamens, Ki Wook Kim, Shaun J Curtin, et al.
Journal of Bacteriology
|
April 20, 2006
Effect of chromate stress on Escherichia coli K-12
D F Ackerley, Y Barak, S V Lynch, et al.
Journal of Visualized Experiments : Jove
|
October 7, 2014
Using the threat probability task to assess anxiety and fear during uncertain and certain threat
Daniel E Bradford, Katherine P Magruder, Rachel A Korhumel, et al.
International Journal of Oral and Maxillofacial Surgery
|
June 22, 2021
Characterization and clinicopathological significance of circulating tumour cells in patients with oral squamous cell carcinoma
J Curtin, S-W Choi, P J Thomson, et al.
Cancers
|
November 26, 2022
Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling
Hannah L Smith, Elaine Willmore, Asima Mukhopadhyay, et al.
Page
of 48